Novel Benchmark Scaling Method for First-in-Human Dose of CAR-T Therapies

被引：0
|
作者：
Zhu, Xu [1 ]
Stein, Andrew [1 ]
Pearson, David [2 ]
Price, Andrew [1 ]
Sohoni, Akash [1 ]
Barton, Nathaniel [1 ]
Bradshaw, Laura [1 ]
Pinzon-Ortiz, Maria [1 ]
Bu, Dexiu [1 ]
Engels, Boris [1 ]
机构：
[1] Novartis Inst Biomed Res, Cambridge, MA USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1124
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [21] Emerging therapies using CAR-T cells in lymphoma
    Salles, Gilles
    Sesques, Pierre
    Ferrant, Emmanuelle
    Safar, Violaine
    Ghesquieres, Herve
    Bachy, Emmanuel
    BULLETIN DU CANCER, 2018, 105 : S168 - S177
  • [22] CAR-T Therapies in Solid Tumors: Opportunities and Challenges
    Guzman, Grace
    Reed, Megan R.
    Bielamowicz, Kevin
    Koss, Brian
    Rodriguez, Analiz
    CURRENT ONCOLOGY REPORTS, 2023, 25 (05) : 479 - 489
  • [23] CAR-T THERAPIES: REIMBURSEMENTS ABOUND, BUT WITH STRINGS ATTACHED
    Sutcliffe, D.
    Macaulay, R.
    Roibu, C.
    Dacosta, Fernandez R.
    VALUE IN HEALTH, 2020, 23 : S69 - S69
  • [24] CAR-T Therapies in Solid Tumors: Opportunities and Challenges
    Grace Guzman
    Megan R. Reed
    Kevin Bielamowicz
    Brian Koss
    Analiz Rodriguez
    Current Oncology Reports, 2023, 25 : 479 - 489
  • [25] Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scaling
    Mahmood, I.
    HAEMOPHILIA, 2014, 20 (01) : 32 - 38
  • [26] Effectiveness and comparison of CAR-T cell therapies for synovial sarcoma; HER2-targeted CAR-T and NKG2D-based CAR-T
    Miyazaki, Tomohiro
    Imai, Chihaya
    Oike, Naoki
    Murayama, Yudai
    Ariizumi, Takashi
    Baba, Minori
    Kasahara, Yasushi
    Kawashima, Hiroyuki
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products
    Alfar, Hammodah R.
    Chen, Cecil
    Lachacz, Eric
    Tang, Weifeng
    Zhang, Yuqian
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [28] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Xin Jin
    Meng Zhang
    Rui Sun
    Hairong Lyu
    Xia Xiao
    Xiaomei Zhang
    Fan Li
    Danni Xie
    Xia Xiong
    Jiaxi Wang
    Wenyi Lu
    Hongkai Zhang
    Mingfeng Zhao
    Journal of Hematology & Oncology, 15
  • [29] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Jin, Xin
    Zhang, Meng
    Sun, Rui
    Lyu, Hairong
    Xiao, Xia
    Zhang, Xiaomei
    Li, Fan
    Xie, Danni
    Xiong, Xia
    Wang, Jiaxi
    Lu, Wenyi
    Zhang, Hongkai
    Zhao, Mingfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [30] CAR-T Cell Therapies From the Transfusion Medicine Perspective
    Fesnak, Andrew
    Lin, ChieYu
    Siegel, Don L.
    Maus, Marcela V.
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (03) : 139 - 145
12345